Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

30OG

HIV-1 CA tri-hexamer interface

Summary for 30OG
Entry DOI10.2210/pdb30og/pdb
EMDB information57891
DescriptorHIV-1 CA (1 entity in total)
Functional Keywordshiv-1 ca, viral protein
Biological sourceHIV-1 group M
Total number of polymer chains6
Total formula weight154569.74
Authors
Goodale, A.,DiMaio, F.,Bergeron, J.R.C. (deposition date: 2026-05-05, release date: 2026-06-24)
Primary citationGoodale, A.,Huang, S.W.,Almeida, N.,Williamson, D.J.,Shkriabai, N.,Betancor, G.,Apolonia, L.,DiMaio, F.,Padilla-Parra, S.,Kvaratskhelia, M.,Bergeron, J.R.C.,Malim, M.H.
MX2 Mediates Collapse of the HIV-1 Capsid.
Biorxiv, 2026
Cited by
PubMed Abstract: The HIV-1 capsid core encapsulates the viral genome and mediates its delivery into the host cell's nucleus. It is composed of multiple copies of the Capsid (CA, p24) protein, assembled into hexamers and pentamers to create a lattice that forms a fullerene-like cone. Myxovirus resistance 2 (MX2) is an HIV-1 restriction factor that binds to the capsid core and blocks nuclear import of the viral genome. Here, we define a minimal region of MX2 required for HIV-1 restriction and produce a corresponding functional recombinant protein. We have used cryo-electron microscopy to determine the structure of this MX2 fragment bound to the tri-hexamer interface of the capsid lattice, revealing a large, buried interface combining electrostatic and hydrophobic interactions. This structure, together with assays that measure capsid core destabilisation, shows that MX2 binding induces conformational rearrangements in the capsid lattice that culminate in a loss of integrity. These results support a model whereby MX2 exerts its antiviral activity by disrupting the capsid lattice, inducing premature fragmentation and preventing HIV-1 nuclear import. By revealing the structural basis for MX2-mediated restriction, this work also provides the framework for the development of anti-HIV molecules that mimic MX2 restriction.
PubMed: 42146390
DOI: 10.64898/2026.05.07.723526
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (4.1 Å)
Structure validation

255615

PDB entries from 2026-06-24

PDB statisticsPDBj update infoContact PDBjnumon